{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:24:39Z","timestamp":1787858679409,"version":"build-2784847793"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Genetic defects in motile cilia cause primary ciliary dyskinesia (PCD), a rare disease with no specific therapeutics. Individuals with PCD often have impaired fertility and laterality defects and universally suffer from upper and lower airway diseases. Chronic rhinosinusitis is a universal feature of PCD, and mucus accumulation and subsequent infections of the sinonasal cavity cause significant morbidity in individuals with PCD. Despite this, there are no approved treatments that specifically target mucus.<\/jats:p><jats:p><jats:bold>Objective:<\/jats:bold> The goals of this study were to determine whether computed tomography (CT) imaging could be used to quantify mucus accumulation and whether the use of a mucolytic agent to reduce disulfide cross-links present in mucins would improve the effectiveness of nasal lavage at removing mucus in a murine model of PCD.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Adult mice with a deletion of the axonemal dynein Dnaic1 were imaged using CT scanning to characterize mucus accumulation. The animals were then treated by nasal lavage with saline, with\/without the disulfide-reducing agent tris(2-carboxyethyl)phosphine. Post-treatment CT scans were used to quantify improvement in the sinonasal cavity.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Mucus accumulation in the nasal cavity was readily quantified by CT. Compared to sham-treated control animals, nasal lavage with\/without a mucolytic agent resulted in a significant reduction of accumulated mucus (<jats:italic>p<\/jats:italic> &amp;lt; 0.01). Treatment with the mucolytic agent showed a greater reduction of accumulated mucus than treatment with saline alone.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The results suggest that inclusion of a mucolytic agent may increase the effectiveness of nasal lavage at reducing mucus burden in PCD.<\/jats:p>","DOI":"10.3389\/fmolb.2023.1221796","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T13:34:45Z","timestamp":1690205685000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Mucolytic treatment of chronic rhinosinusitis in a murine model of primary ciliary dyskinesia"],"prefix":"10.3389","volume":"10","author":[{"given":"Weining","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Golliher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia S.","family":"Kimbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Livraghi-Butrico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy D.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara R.","family":"Grubb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Kimple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence E.","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.2146\/ajhp060568","article-title":"Effect of dilution with beverages on the smell and taste of oral acetylcysteine","volume":"64","author":"Crouch","year":"2007","journal-title":"Am. J. Health Syst. Pharm."},{"key":"B2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1398-9995.1971.tb01294.x","article-title":"Bronchospasm caused by acetylcysteine in children with bronchial asthma","volume":"26","author":"Dano","year":"1971","journal-title":"Acta Allergol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1164\/rccm.201409-1672OC","article-title":"Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype","volume":"191","author":"Davis","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1513\/AnnalsATS.201603-198OC","article-title":"Primary ciliary dyskinesia: First health-related quality-of-life measures for pediatric patients","volume":"13","author":"Dell","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"B5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1164\/rccm.201802-0245OC","article-title":"An improved inhaled mucolytic to treat airway muco-obstructive diseases","volume":"199","author":"Ehre","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S2213-2600(21)00453-7","article-title":"The global prevalence and ethnic heterogeneity of primary ciliary dyskinesia gene variants: A genetic database analysis","volume":"10","author":"Hannah","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ccm.2016.04.008","article-title":"Primary ciliary dyskinesia","volume":"37","author":"Knowles","year":"2016","journal-title":"Clin. chest Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00018-020-03633-5","article-title":"Motile cilia genetics and cell biology: Big results from little mice","volume":"78","author":"Lee","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nature14269","article-title":"Global genetic analysis in mice unveils central role for cilia in congenital heart disease","volume":"521","author":"Li","year":"2015","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1183\/09031936.00216214","article-title":"A quality-of-life measure for adults with primary ciliary dyskinesia: QOL-PCD","volume":"46","author":"Lucas","year":"2015","journal-title":"Eur. Respir. J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41467-020-20499-0","article-title":"Disulfide disruption reverses mucus dysfunction in allergic airway disease","volume":"12","author":"Morgan","year":"2021","journal-title":"Nat. Commun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1165\/rcmb.2009-0118OC","article-title":"Conditional deletion of dnaic1 in a murine model of primary ciliary dyskinesia causes chronic rhinosinusitis","volume":"43","author":"Ostrowski","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"107916","DOI":"10.1016\/j.pharmthera.2021.107916","article-title":"The mechanism of action of N-acetylcysteine (NAC): The emerging role of H(2)S and sulfane sulfur species","volume":"228","author":"Pedre","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ppul.23304","article-title":"Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review","volume":"51","author":"Shapiro","year":"2016","journal-title":"Pediatr. Pulmonol."},{"key":"B15","volume-title":"Primary ciliary dyskinesia","author":"Zariwala","year":"2015"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1221796\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T13:34:50Z","timestamp":1690205690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1221796\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":15,"alternative-id":["10.3389\/fmolb.2023.1221796"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2023.1221796","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]},"article-number":"1221796"}}